Effect of cefoperazone sulbactam on the efficacy of sepsis and the inflammatory factors of IL-6, IL-10, IL-1 and CRP
10.3969/j.issn.1005-1678.2017.08.108
- VernacularTitle:头孢哌酮舒巴坦对脓毒血症患者疗效及IL-6、IL-10、IL-1、CRP炎症因子的影响分析
- Author:
Xiangfei PENG
;
Mingxing LUO
- Keywords:
cefoperazone and sulbactam;
sepsis;
efficacy;
inflammatory cytokines
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(8):257-258,261
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of cefoperazone sulbactam on the efficacy inflammatory factors in patients with sepsis. Methods 80 cases of sepsis patients from January 2014 to April 2015, were double-blindly, randomized divided into control group(41 cases) and observation group(39 cases). The control group was treated with conventional treatment methods, the observation group was treated with cefoperazone sulbactam. After treatment, Leukocyte IL-6, IL-10, IL-1 and C- reactive protein (CRP) levels of interleukin and curative effect in the two groups were analyzed. Results After treatment, the levels of IL-6, IL-10, IL-1, CRP in the observation group were lower than those in the control group (t=15.555;t=11.122; t=9.379; t=34.782), the difference was statistically significant (P<0.05); The total effective rate in the observation group was 95.12%, which was significantly higher than that in the control group (76.93%), and the difference was statistically significant (P<0.05); The proportion of painless and severe pain in the observation group was significantly lower than that in the control group(76.93%), and the difference was statistically significant (P<0.05). Conclusion Cefoperazone sulbactam is effective in the treatment of sepsis, can improve the efficacy of treatment, it is a safe and effective treatment, should be promoted and used in clinical.
